William P. Schiemann

14.6k total citations · 1 hit paper
132 papers, 11.1k citations indexed

About

William P. Schiemann is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, William P. Schiemann has authored 132 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 55 papers in Oncology and 33 papers in Cancer Research. Recurrent topics in William P. Schiemann's work include TGF-β signaling in diseases (45 papers), Cancer Cells and Metastasis (38 papers) and Cell Adhesion Molecules Research (25 papers). William P. Schiemann is often cited by papers focused on TGF-β signaling in diseases (45 papers), Cancer Cells and Metastasis (38 papers) and Cell Adhesion Molecules Research (25 papers). William P. Schiemann collaborates with scholars based in United States, Brazil and China. William P. Schiemann's co-authors include Harvey F. Lodish, Gerard C. Blobe, Michael K. Wendt, Maozhen Tian, Molly A. Taylor, Jason R. Neil, Jenny G. Parvani, Allan R. Albig, Barbara J. Schiemann and Tressa M. Allington and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

William P. Schiemann

129 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Transforming Growth Factor β in Human Disease

2000 2.0k citations William P. Schiemann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William P. Schiemann United States	59	6.8k	3.5k	2.4k	1.3k	1.3k	132	11.1k
Neil A. Bhowmick United States	51	6.8k 1.0×	4.3k 1.2×	2.6k 1.1×	1.2k 0.9×	2.0k 1.6×	144	11.4k
Olga V. Volpert United States	57	8.4k 1.2×	2.3k 0.7×	4.0k 1.6×	1.3k 1.0×	878 0.7×	107	12.5k
Gerard C. Blobe United States	52	6.6k 1.0×	3.0k 0.9×	1.4k 0.6×	919 0.7×	1.2k 1.0×	135	10.4k
Kevin P. Claffey United States	52	7.6k 1.1×	3.0k 0.8×	2.5k 1.0×	1.4k 1.1×	768 0.6×	98	11.7k
Reuven Reich Israel	59	5.4k 0.8×	3.0k 0.9×	3.4k 1.4×	1.8k 1.4×	863 0.7×	202	11.2k
Evelyn Flynn United States	36	6.8k 1.0×	2.5k 0.7×	3.1k 1.3×	864 0.7×	1.1k 0.9×	66	11.4k
Humphrey Gardner United States	50	4.5k 0.7×	2.7k 0.8×	1.5k 0.6×	1.1k 0.8×	1.2k 0.9×	102	9.0k
Gordon Stamp United Kingdom	59	7.2k 1.1×	5.0k 1.4×	2.6k 1.1×	2.1k 1.6×	1.0k 0.8×	118	12.5k
Ying E. Zhang United States	51	12.5k 1.8×	3.5k 1.0×	2.4k 1.0×	1.3k 1.0×	1.3k 1.0×	102	16.4k
Herbert A. Weich Germany	52	7.7k 1.1×	3.2k 0.9×	2.9k 1.2×	1.1k 0.9×	933 0.7×	114	11.9k

Countries citing papers authored by William P. Schiemann

Since Specialization

Citations

This map shows the geographic impact of William P. Schiemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Schiemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Schiemann more than expected).

Fields of papers citing papers by William P. Schiemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Schiemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Schiemann. The network helps show where William P. Schiemann may publish in the future.

Co-authorship network of co-authors of William P. Schiemann

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Schiemann. A scholar is included among the top collaborators of William P. Schiemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Schiemann. William P. Schiemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erokwu, Bernadette O., Barbara J. Schiemann, Chunying Wu, et al.. (2025). Dynamic contrast enhanced‐magnetic resonance fingerprinting (DCE‐MRF): A new quantitative MRI method to reliably assess tumor vascular perfusion. Magnetic Resonance in Medicine. 94(6). 2578–2592. 1 indexed citations

Seachrist, Darcie D., Zhenghao Liu, Ruth A. Keri, et al.. (2024). The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer. Cell Death and Differentiation. 31(6). 768–778. 5 indexed citations

Moon, Taylor J., et al.. (2023). Can targeted nanoparticles distinguish cancer metastasis from inflammation?. Journal of Controlled Release. 362. 812–819. 2 indexed citations

Kim, Jiyoon, Da Sun, Ryan Hall, et al.. (2023). Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging. SHILAP Revista de lepidopterología. 1(5). 461–470. 18 indexed citations

Diamond, Jennifer R., Todd M. Pitts, Dana Ungermannova, et al.. (2021). Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(3). 397–406. 10 indexed citations

Vaidya, Amita, Zhanhu Sun, Nadia Ayat, et al.. (2019). Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy. Bioconjugate Chemistry. 30(3). 907–919. 142 indexed citations

Sossey‐Alaoui, Khalid, Elżbieta Pluskota, Katarzyna Białkowska, et al.. (2017). Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1–Mediated Macrophage Infiltration. Cancer Research. 77(18). 5129–5141. 55 indexed citations

Zheng, Han, et al.. (2017). Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer. Nature Communications. 8(1). 692–692. 65 indexed citations

Thomas, Dustin, Céline Denais, Andrew D. Rape, et al.. (2015). Non-muscle myosin IIB is critical for nuclear translocation during 3D invasion. The Journal of Cell Biology. 210(4). 583–594. 106 indexed citations

10.

Peiris, Pubudu M., Partha Deb, Elizabeth Doolittle, et al.. (2015). Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis. Journal of Pharmaceutical Sciences. 104(8). 2600–2610. 46 indexed citations

11.

Lee, Yong‐Hun & William P. Schiemann. (2013). Chemotherapeutic targeting of the TGF-β pathway in breast cancers. PubMed. 3(1). 73–85. 4 indexed citations

12.

Wendt, Michael K. & William P. Schiemann. (2013). Longitudinal Bioluminescent Quantification of Three Dimensional Cell Growth. BIO-PROTOCOL. 3(23). 1 indexed citations

13.

Micalizzi, Douglas S., Chu-An Wang, Susan M. Farabaugh, William P. Schiemann, & Heide L. Ford. (2010). Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth. Cancer Research. 70(24). 10371–10380. 92 indexed citations

14.

Wendt, Michael K., John A. Smith, & William P. Schiemann. (2010). Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene. 29(49). 6485–6498. 171 indexed citations

15.

Micalizzi, Douglas S., Kimberly Christensen, Paul Jedlicka, et al.. (2009). The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling. Journal of Clinical Investigation. 119(9). 2678–2690. 196 indexed citations

16.

Neil, Jason R. & William P. Schiemann. (2008). Altered TAB1:IκB Kinase Interaction Promotes Transforming Growth Factor β–Mediated Nuclear Factor-κB Activation during Breast Cancer Progression. Cancer Research. 68(5). 1462–1470. 69 indexed citations

17.

Xiao, Yi, Célio Geraldo Freire-de-Lima, William P. Schiemann, et al.. (2008). Transcriptional and Translational Regulation of TGF-β Production in Response to Apoptotic Cells. The Journal of Immunology. 181(5). 3575–3585. 114 indexed citations

18.

Albig, Allan R. & William P. Schiemann. (2004). Fibulin-5 Antagonizes Vascular Endothelial Growth Factor (VEGF) Signaling and Angiogenic Sprouting by Endothelial Cells. DNA and Cell Biology. 23(6). 367–379. 104 indexed citations

19.

Albig, Allan R. & William P. Schiemann. (2004). Identification and Characterization of Regulator of G Protein Signaling 4 (RGS4) as a Novel Inhibitor of Tubulogenesis: RGS4 Inhibits Mitogen-activated Protein Kinases and Vascular Endothelial Growth Factor Signaling. Molecular Biology of the Cell. 16(2). 609–625. 58 indexed citations

20.

Cosgrove, Gregory P., Kevin K. Brown, William P. Schiemann, et al.. (2004). Pigment Epithelium–derived Factor in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 170(3). 242–251. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact